TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
BCYC

Bicycle Therapeutics Ltd

Healthcare · Biotechnology

3.70$ +0.7% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement BCYC
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
– 576.0% 290.9% 185.1% 319.0% 383.7% 25.5% 580.1% 490.3% 8.9%
– -476.0% -190.9% 100.0% -219.0% 100.0% 100.0% -480.1% -390.3% 100.0%
– 576.0% 290.9% 185.1% 319.0% 383.7% 564.3% 580.1% 490.3% 331.0%
– 311.0% 113.8% 105.5% 281.0% 277.3% 342.3% 221.8% 202.6% 110.2%
– 887.0% 404.7% 290.6% 281.0% 661.0% 906.6% 224.0% 204.6% 441.3%
– -787.0% -304.7% -190.6% -500.1% -561.0% -806.6% -704.1% -595.0% -341.3%
– 0.0% 0.0% 26.1% 4.4% 25.5% 23.1% 12.1% 4.9% 0.3%
– -790.4% -311.7% -223.6% -497.9% -585.5% -789.9% -664.3% -492.7% -301.4%
– -1.1% -5.5% -1.8% -7.0% -14.2% -10.5% 5.4% -13.5% 0.2%
– -789.3% -306.1% -221.8% -491.0% -571.2% -779.3% -669.7% -479.2% -301.7%
– -770.9% -301.2% -183.6% -487.8% -547.9% -741.3% -628.0% -467.4% -292.3%

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?